These guidelines are a tool to support a physician's best clinical judgement for hospice eligibility. A patient who does not meet these guidelines may still be eligible for hospice due to comorbidities or rapid functional decline.
1. At the time of initial certification or recertification for hospice:
- Patient is already optimally treated with diuretics and vasodilators, which may include Angiotensin-converting enzyme (ACE) inhibitors or the combination of hydralazine and nitrates. If side effects, such as hypotension or hyperkalemia, prohibit the use of ACE inhibitors or the combination of hydralazine and nitrates, this must be documented in the medical records;
- Patients having angina pectoris, at rest, resistant to standard nitrate therapy and are either not candidates or decline invasive procedures.
2. The patient has significant symptoms of recurrent congestive heart failure (CHF) at rest, and is classified as a New York Heart Association (NYHA) Class IV.
- Unable to carry on any physical activity without symptoms;
- Symptoms are present even at rest;
- If any physical activity is undertaken, symptoms are increased.
- Treatment resistant symptomatic supraventricular or ventricular arrhythmias;
- History of cardiac arrest or resuscitation;
- History of unexplained syncope;
- Brain embolism of cardiac origin;
- Concomitant HIV disease;
- Documentation of ejection fraction of 20% or less (only if available)
If a patient meets the medical criteria above, they are by definition eligible to receive hospice services.